AI assistant
Natco Pharma Ltd. — Call Transcript 2020
Aug 5, 2020
62741_rns_2020-08-05_3b979658-10c8-4151-be79-f612a0c7f91a.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [416 x 43] intentionally omitted <==
August 5, 2020
Corporate Relationship Department Manager – Listing M/s. BSE Ltd M/s. National Stock Exchange of India Ltd Dalal Street, Fort “Exchange Plaza”, Bandra – Kurla Complex Mumbai- 400 001 Bandra (E) Mumbai -400 051 Scrip Code: 524816 Scrip Code: NATCOPHARM
Dear Sir
Sub: - Earning call for Q1 FY21
The Company will host an Earnings Call with Investors / Analysts at 11.00 a.m. IST on August 13, 2020 to disseminate Financial Results of the company for the quarter ended June 30, 2020.
A Copy of the same is enclosed for your ready reference
Thanking you
Yours faithfully For NATCO Pharma Limited
ADINARAYANA MADINEEDI Digitally signed by ADINARAYANA MADINEEDI DN: c=IN, o=Personal, 2.5.4.20=98307de121abc9bab67f3e00bc3fdead0597f7b7c44a25eaab89442f8748d254, postalCode=500017, st=TELANGANA, serialNumber=3da487f04b8912870dea3f277d9e87fc06da96e80b36d2beb1428dfe3f665de7, cn=ADINARAYANA MADINEEDI Date: 2020.08.05 11:09:00 +05'30'
M Adinarayana Company Secretary & Vice President (Legal & Corp Affairs)
==> picture [130 x 36] intentionally omitted <==
Axis House, C-2, Wadia International Centre, P.B Marg. Worli, Mumbai 400 025 (India)
==> picture [107 x 45] intentionally omitted <==
Natco Pharma
Q1FY21 Earnings Call on 13[th] August 2020 hosted by Axis Capital Limited
We are pleased to host, on behalf of Natco Pharma, a conference call for analysts and investors on Thursday, 13[th] August 2020, following the announcement of financial results for the first quarter ended June 2020.
The call will be initiated with a brief management discussion on the Q1FY21 earnings performance followed by an interactive Question & Answer session. The management will be represented by
-
Mr. Rajeev Nannapaneni : Vice Chairman and Chief Executive Officer
-
Mr. Rajesh Chebiyam : Vice President – Acquisitions, Institutional Investor Management and Corporate Communications
Details of conference call
| Date | : | Thursday, 13thAugust 2020 |
|---|---|---|
| Time | : | 11:00 AM IST |
| Call leader | : | Mr. Prakash Agarwal, Axis Capital |
| Country | Dial in numbers |
|---|---|
| Primarynumber | +91 22 6280 1145/+ 91 22 7115 8046 |
| India Local | +91 7045671221(available all over India) |
| International Dial in | |
| - Hong Kong | 800 964 448 |
| - Singapore | 800 101 2045 |
| - U K | 0 808 101 1573 |
| - USA | 1 866 746 2133 |
Diamond pass registration – for pre registration
Copy this URL in your browser:
= https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber 6442430&linkSecurity String=1101028570
For further information please contact:
Prakash Agarwal
Dy Head – Research | Executive Director – Pharma Institutional Equity Research Axis Capital Limited Direct: +91 22 4325 1145 Board: +91 22 4325 2525 Mobile: +91 9820534334 Email: [email protected]